The opportunity
Teva is implementing its ambitious Pivot to Growth strategy, with biosimilars serving as a cornerstone of the company's success. As part of Teva's commitment to establishing leadership in biosimilars, this role plays a pivotal part in expanding the company’s biosimilar franchise and driving the commercialization of one of the most extensive biosimilars pipelines in the industry.
The position leads the inline business, currently consisting of two established oncology biosimilar brands TRUXIMA® and HERZUMA®. The position manages the P&L and ensures late life cycle success through strategic efforts guided by in depth understanding of reimbursement dynamics.
How you’ll spend your day
Leads inline brand management for TRUXIMA and HERZUMA, two oncology buy-and-bill biosimilars
Manages P&L focusing on revenue stabilization and gross-to-net optimization
Leads relaunch efforts on HERZUMA
Applies strategies to establish long-term sustainability considering pricing, reimbursement, customer mix and 340b dynamics
Understands needs and dynamics of key customers such as GPOs (clinic/hospital), 340b, payers
Collaborates with payer marketing on pricing and contracting
Collaborates on marketing plan and tactics with marketing operations for TRUXIMA and HERZUMA
Collaborates with the matrix biosimilars marketing team as well as with the wider cross-functional team to deliver on set objectives
Collaborates with finance and forecasting on financial planning
Collaborates with forecasting on supply planning
Drives performance tracking to support inline products in collaboration with the insights/data team, analyzes market data and information and makes informed decisions
Supports Business Development assessments for inline opportunities
Understands and stays up to date with biosimilar market dynamics and policy matters
Aligns organizationally and individually with internal and external codes of conduct
